Literature DB >> 19106409

Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art.

Bruce H Gray, Michael S Conte, Michael D Dake, Michael R Jaff, Krishna Kandarpa, Stephen R Ramee, John Rundback, Ronald Waksman.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19106409     DOI: 10.1161/CIRCULATIONAHA.108.191177

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Peripheral artery disease. Part 2: medical and endovascular treatment.

Authors:  Mitchell D Weinberg; Joe F Lau; Kenneth Rosenfield; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

2.  Peripheral artery disease: current insight into the disease and its diagnosis and management.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

3.  Role of surgical treatment for peripheral arterial disease in endovascular era.

Authors:  Sang Jun Park; Jae Chol Hwang; Hong Rae Cho; Ho Jong Park; Sang Jin Kim; Bong Won Park
Journal:  J Korean Surg Soc       Date:  2013-05-28

4.  Serum-derived extracellular vesicles (EVs) impact on vascular remodeling and prevent muscle damage in acute hind limb ischemia.

Authors:  Claudia Cavallari; Andrea Ranghino; Marta Tapparo; Massimo Cedrino; Federico Figliolini; Cristina Grange; Valentina Giannachi; Paolo Garneri; Maria Chiara Deregibus; Federica Collino; Pietro Rispoli; Giovanni Camussi; Maria Felice Brizzi
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

5.  Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression.

Authors:  Gabriele Togliatto; Antonella Trombetta; Patrizia Dentelli; Paolo Cotogni; Arturo Rosso; Matthias H Tschöp; Riccarda Granata; Ezio Ghigo; Maria F Brizzi
Journal:  J Am Heart Assoc       Date:  2013-12-05       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.